At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active ...
TIESA will use Open-LIFU in AI-guided, noninvasive research on neuromodulation for mental health conditions. SAN ...
Spiro Medical announced today that it closed a $67 million Series A equity financing to support its neuromodulation system.
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed ...
Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation ...
Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing ...
A major step toward the industrialization of brain-computer interface technology was taken recently as NeuroXess, a Chinese ...
11d
Spiro Medical Secures $67 Million Series A Financing to Develop a Neuromodulation System for Asthma
Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the ...
11don MSNOpinion
Two technologies, one disease: Connecting DBS and focused ultrasound for Parkinson's disease management
Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people ...
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback